<code id='49C398F70A'></code><style id='49C398F70A'></style>
    • <acronym id='49C398F70A'></acronym>
      <center id='49C398F70A'><center id='49C398F70A'><tfoot id='49C398F70A'></tfoot></center><abbr id='49C398F70A'><dir id='49C398F70A'><tfoot id='49C398F70A'></tfoot><noframes id='49C398F70A'>

    • <optgroup id='49C398F70A'><strike id='49C398F70A'><sup id='49C398F70A'></sup></strike><code id='49C398F70A'></code></optgroup>
        1. <b id='49C398F70A'><label id='49C398F70A'><select id='49C398F70A'><dt id='49C398F70A'><span id='49C398F70A'></span></dt></select></label></b><u id='49C398F70A'></u>
          <i id='49C398F70A'><strike id='49C398F70A'><tt id='49C398F70A'><pre id='49C398F70A'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:539
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Laying a path for careers in science
          Laying a path for careers in science

          HighschoolstudentsconductedanexperimentattheBiogenCommunityLabinCambridge.Morethan25,000haveparticip

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Bernie brings in new pharma CEOs to talk drug prices

          Sen.BernieSanders(I-Vt.)Moneymaker/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-